Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and design

Abstract Introduction The Alzheimer's biomarkers in daily practice (ABIDE) project is designed to translate knowledge on diagnostic tests (magnetic resonance imaging [MRI], cerebrospinal fluid [CSF], and amyloid positron emission tomography [PET]) to daily clinical practice with a focus on mild...

Full description

Saved in:
Bibliographic Details
Published inAlzheimer's & dementia : diagnosis, assessment & disease monitoring Vol. 6; no. 1; pp. 143 - 151
Main Authors de Wilde, Arno, van Maurik, Ingrid S, Kunneman, Marleen, Bouwman, Femke, Zwan, Marissa, Willemse, Eline A.J, Biessels, Geert Jan, Minkman, Mirella, Pel, Ruth, Schoonenboom, Niki S.M, Smets, Ellen M.A, Wattjes, Mike P, Barkhof, Frederik, Stephens, Andrew, van Lier, Erik J, Batrla-Utermann, Richard, Scheltens, Philip, Teunissen, Charlotte E, van Berckel, Bart N.M, van der Flier, Wiesje M
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 2017
Elsevier
Subjects
Alzheimer's disease
Biomarkers
Clinical practice
Dementia
Diagnostic Assessment & Prognosis
Mild cognitive impairment
Neurology
Other
Biomarkers
Mild cognitive impairment
Alzheimer's disease
Clinical practice
Dementia
Online AccessGet full text
ISSN2352-8729
2352-8729
DOI10.1016/j.dadm.2017.01.003

Cover

Abstract Abstract Introduction The Alzheimer's biomarkers in daily practice (ABIDE) project is designed to translate knowledge on diagnostic tests (magnetic resonance imaging [MRI], cerebrospinal fluid [CSF], and amyloid positron emission tomography [PET]) to daily clinical practice with a focus on mild cognitive impairment (MCI) Methods ABIDE is a 3-year project with a multifaceted design and is structured into interconnected substudies using both quantitative and qualitative research methods. Results Based on retrospective data, we develop personalized risk estimates for MCI patients. Prospectively, we collect MRI and CSF data from 200 patients from local memory clinics and amyloid PET from 500 patients in a tertiary setting, to optimize application of these tests in daily practice. Furthermore, ABIDE will develop strategies for optimal patient-clinician conversations. Discussion Ultimately, this will result in a set of practical tools for clinicians to support the choice of diagnostic tests and facilitate the interpretation and communication of their results.
AbstractList Abstract Introduction The Alzheimer's biomarkers in daily practice (ABIDE) project is designed to translate knowledge on diagnostic tests (magnetic resonance imaging [MRI], cerebrospinal fluid [CSF], and amyloid positron emission tomography [PET]) to daily clinical practice with a focus on mild cognitive impairment (MCI) Methods ABIDE is a 3-year project with a multifaceted design and is structured into interconnected substudies using both quantitative and qualitative research methods. Results Based on retrospective data, we develop personalized risk estimates for MCI patients. Prospectively, we collect MRI and CSF data from 200 patients from local memory clinics and amyloid PET from 500 patients in a tertiary setting, to optimize application of these tests in daily practice. Furthermore, ABIDE will develop strategies for optimal patient-clinician conversations. Discussion Ultimately, this will result in a set of practical tools for clinicians to support the choice of diagnostic tests and facilitate the interpretation and communication of their results.
The Alzheimer's biomarkers in daily practice (ABIDE) project is designed to translate knowledge on diagnostic tests (magnetic resonance imaging [MRI], cerebrospinal fluid [CSF], and amyloid positron emission tomography [PET]) to daily clinical practice with a focus on mild cognitive impairment (MCI) ABIDE is a 3-year project with a multifaceted design and is structured into interconnected substudies using both quantitative and qualitative research methods. Based on retrospective data, we develop personalized risk estimates for MCI patients. Prospectively, we collect MRI and CSF data from 200 patients from local memory clinics and amyloid PET from 500 patients in a tertiary setting, to optimize application of these tests in daily practice. Furthermore, ABIDE will develop strategies for optimal patient-clinician conversations. Ultimately, this will result in a set of practical tools for clinicians to support the choice of diagnostic tests and facilitate the interpretation and communication of their results.
Introduction The Alzheimer's biomarkers in daily practice (ABIDE) project is designed to translate knowledge on diagnostic tests (magnetic resonance imaging [MRI], cerebrospinal fluid [CSF], and amyloid positron emission tomography [PET]) to daily clinical practice with a focus on mild cognitive impairment (MCI) Methods ABIDE is a 3‐year project with a multifaceted design and is structured into interconnected substudies using both quantitative and qualitative research methods. Results Based on retrospective data, we develop personalized risk estimates for MCI patients. Prospectively, we collect MRI and CSF data from 200 patients from local memory clinics and amyloid PET from 500 patients in a tertiary setting, to optimize application of these tests in daily practice. Furthermore, ABIDE will develop strategies for optimal patient‐clinician conversations. Discussion Ultimately, this will result in a set of practical tools for clinicians to support the choice of diagnostic tests and facilitate the interpretation and communication of their results.
The Alzheimer's biomarkers in daily practice (ABIDE) project is designed to translate knowledge on diagnostic tests (magnetic resonance imaging [MRI], cerebrospinal fluid [CSF], and amyloid positron emission tomography [PET]) to daily clinical practice with a focus on mild cognitive impairment (MCI).INTRODUCTIONThe Alzheimer's biomarkers in daily practice (ABIDE) project is designed to translate knowledge on diagnostic tests (magnetic resonance imaging [MRI], cerebrospinal fluid [CSF], and amyloid positron emission tomography [PET]) to daily clinical practice with a focus on mild cognitive impairment (MCI).ABIDE is a 3-year project with a multifaceted design and is structured into interconnected substudies using both quantitative and qualitative research methods.METHODSABIDE is a 3-year project with a multifaceted design and is structured into interconnected substudies using both quantitative and qualitative research methods.Based on retrospective data, we develop personalized risk estimates for MCI patients. Prospectively, we collect MRI and CSF data from 200 patients from local memory clinics and amyloid PET from 500 patients in a tertiary setting, to optimize application of these tests in daily practice. Furthermore, ABIDE will develop strategies for optimal patient-clinician conversations.RESULTSBased on retrospective data, we develop personalized risk estimates for MCI patients. Prospectively, we collect MRI and CSF data from 200 patients from local memory clinics and amyloid PET from 500 patients in a tertiary setting, to optimize application of these tests in daily practice. Furthermore, ABIDE will develop strategies for optimal patient-clinician conversations.Ultimately, this will result in a set of practical tools for clinicians to support the choice of diagnostic tests and facilitate the interpretation and communication of their results.DISCUSSIONUltimately, this will result in a set of practical tools for clinicians to support the choice of diagnostic tests and facilitate the interpretation and communication of their results.
Author de Wilde, Arno
Bouwman, Femke
Willemse, Eline A.J
Teunissen, Charlotte E
van Maurik, Ingrid S
Biessels, Geert Jan
Minkman, Mirella
Stephens, Andrew
van Lier, Erik J
Wattjes, Mike P
Batrla-Utermann, Richard
van der Flier, Wiesje M
Kunneman, Marleen
Zwan, Marissa
Smets, Ellen M.A
Pel, Ruth
Barkhof, Frederik
van Berckel, Bart N.M
Schoonenboom, Niki S.M
Scheltens, Philip
AuthorAffiliation j Piramal Imaging GmbH, Berlin, Germany
e Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands
l Roche Diagnostics, Basel, Switzerland
a Department of Neurology & Alzheimer Center, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands
d Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands
g Department of Neurology, Spaarne Gasthuis, Haarlem, The Netherlands
k BV Cyclotron, Amsterdam, The Netherlands
c Department of Medical Psychology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
f Vilans, Utrecht, The Netherlands
h Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands
b Department of Epidemiology and Biostatistics, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands
i Institu
AuthorAffiliation_xml – name: j Piramal Imaging GmbH, Berlin, Germany
– name: d Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands
– name: g Department of Neurology, Spaarne Gasthuis, Haarlem, The Netherlands
– name: f Vilans, Utrecht, The Netherlands
– name: a Department of Neurology & Alzheimer Center, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands
– name: b Department of Epidemiology and Biostatistics, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands
– name: h Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands
– name: c Department of Medical Psychology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
– name: e Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands
– name: k BV Cyclotron, Amsterdam, The Netherlands
– name: i Institutes of Neurology and Healthcare Engineering, UCL, London, UK
– name: l Roche Diagnostics, Basel, Switzerland
Author_xml – sequence: 1
  fullname: de Wilde, Arno
– sequence: 2
  fullname: van Maurik, Ingrid S
– sequence: 3
  fullname: Kunneman, Marleen
– sequence: 4
  fullname: Bouwman, Femke
– sequence: 5
  fullname: Zwan, Marissa
– sequence: 6
  fullname: Willemse, Eline A.J
– sequence: 7
  fullname: Biessels, Geert Jan
– sequence: 8
  fullname: Minkman, Mirella
– sequence: 9
  fullname: Pel, Ruth
– sequence: 10
  fullname: Schoonenboom, Niki S.M
– sequence: 11
  fullname: Smets, Ellen M.A
– sequence: 12
  fullname: Wattjes, Mike P
– sequence: 13
  fullname: Barkhof, Frederik
– sequence: 14
  fullname: Stephens, Andrew
– sequence: 15
  fullname: van Lier, Erik J
– sequence: 16
  fullname: Batrla-Utermann, Richard
– sequence: 17
  fullname: Scheltens, Philip
– sequence: 18
  fullname: Teunissen, Charlotte E
– sequence: 19
  fullname: van Berckel, Bart N.M
– sequence: 20
  fullname: van der Flier, Wiesje M
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28239639$$D View this record in MEDLINE/PubMed
BookMark eNqNUk1vEzEQXaEiWkr_AAe0N8ohwWOv9wNVldKmQFEBiY_zyPHOtk4dO9ibovTX10taVHqouNjWzLw34_fmebblvKMsewlsDAzKt_Nxq9rFmDOoxgzGjIkn2Q4Xko_qijdb997b2V6Mc8YYFA0vgD3LtnnNRVOKZif7MrHXF2QWFF7HfGb8QoVLCjE3Lm-Vset8GZTujaZ8f3J0Oj15kwJ-Trp_l39TvfFOWcqVa_OWojl3L7KnnbKR9m7v3ezn-5Mfxx9HZ18_nB5Pzka6qAsxarmSdQldwUtNM9aVErju2qKpCg1lA0J2TUo2vGqokzPZCSXLNDBIYBqKUuxmhxve5Wq2oFaT64OyuAwmfWCNXhn8N-PMBZ77K5QCallAIti_JQj-14pijwsTNVmrHPlVREjKyVpAxVLpq_u9_ja5EzEV1JsCHXyMgTrUpv8jTmptLALDwTKc42AZDpYhA0yWJSh_AL1jfxR0tAH9NpbW_4HA6WTKP6Xj8xBksCE52JBQsunKUMCoDTlNrQnJXmy9eXyGwwdwbY0zWtlLWlOc-1VIq5F0xMiR4fdhG4dlhEqkTUyi3QBRNNX9
CitedBy_id crossref_primary_10_1002_dad2_70063
crossref_primary_10_1111_ene_14668
crossref_primary_10_1177_1471301220969269
crossref_primary_10_3233_JAD_170850
crossref_primary_10_1111_hex_12964
crossref_primary_10_1016_j_dadm_2018_08_006
crossref_primary_10_1002_alz_12846
crossref_primary_10_1016_j_nicl_2020_102504
crossref_primary_10_1002_dad2_12063
crossref_primary_10_1097_MD_0000000000016509
crossref_primary_10_1155_2022_9960832
crossref_primary_10_3389_fpsyt_2020_585686
crossref_primary_10_1002_dad2_12182
crossref_primary_10_1016_j_dadm_2019_04_005
crossref_primary_10_1016_j_jamda_2020_10_020
crossref_primary_10_3233_JAD_180381
crossref_primary_10_3233_JAD_220024
crossref_primary_10_1016_j_trci_2017_04_002
crossref_primary_10_2967_jnumed_118_207811
crossref_primary_10_1016_j_jalz_2019_07_003
crossref_primary_10_3389_fneur_2024_1320653
crossref_primary_10_1002_alz_12150
crossref_primary_10_1001_jamaneurol_2018_1346
crossref_primary_10_1373_clinchem_2017_281055
crossref_primary_10_1007_s12474_018_00203_1
crossref_primary_10_1212_WNL_0000000000010256
crossref_primary_10_2196_13417
crossref_primary_10_1159_000511233
crossref_primary_10_1111_ene_13945
crossref_primary_10_1007_s00259_020_05187_x
crossref_primary_10_1016_j_dadm_2019_06_001
crossref_primary_10_1371_journal_pone_0303111
crossref_primary_10_3233_JAD_180292
crossref_primary_10_3233_ADR_220064
crossref_primary_10_3233_JAD_215342
crossref_primary_10_1002_dad2_12120
crossref_primary_10_1371_journal_pone_0227282
crossref_primary_10_1002_trc2_12113
crossref_primary_10_1007_s00330_021_08503_7
crossref_primary_10_1001_jamanetworkopen_2022_50921
crossref_primary_10_1186_s13195_023_01351_1
crossref_primary_10_1002_alz_12622
crossref_primary_10_1002_alz_12886
crossref_primary_10_1002_dad2_12229
crossref_primary_10_1186_s13195_019_0561_5
crossref_primary_10_1016_j_nrleng_2018_03_006
crossref_primary_10_1186_s13195_024_01543_3
crossref_primary_10_1016_j_nrl_2018_03_006
Cites_doi 10.1016/j.jalz.2016.02.002
10.1126/scitranslmed.3007941
10.1006/nimg.2002.1040
10.1001/jama.2009.1064
10.1016/j.jalz.2016.07.150
10.1016/j.jalz.2013.01.010
10.1136/bmjopen‐2012‐002541
10.1186/s13195-015-0112-7
10.1016/S1474-4422(11)70123-5
10.1001/archneurol.2009.266
10.1016/S1474-4422(15)00093-9
10.1038/nrneurol.2009.215
10.1016/j.jalz.2014.12.001
10.1159/000117270
10.1016/j.jalz.2013.01.002
10.1212/WNL.0b013e3181e8e8b8
10.1016/S0084-3954(09)79610-1
10.1159/000315542
10.1016/j.jalz.2011.03.008
10.1016/j.jalz.2012.07.003
10.1002/ana.20009
10.1093/brain/awv029
10.1001/jamaneurol.2016.3751
10.1016/j.jalz.2014.10.014
10.1136/jnnp.55.10.967
10.2214/ajr.149.2.351
10.1016/S2215-0366(15)00454-X
10.1001/archneur.56.3.303
10.1212/WNL.0b013e31823ed0f0
10.3233/JAD-132306
10.1016/j.jalz.2015.09.009
10.1373/clinchem.2009.130518
10.1016/S0304-3940(00)01036-3
10.1016/S0140-6736(15)01124-1
10.3389/fnins.2015.00345
10.3109/13506120009146438
10.1016/S1474-4422(14)70211-X
10.1016/j.jalz.2013.02.005
10.1002/gps.3925
10.1007/s00330-011-2205-4
10.3233/JAD-2011-110458
10.1016/j.jalz.2011.03.005
10.1038/nrneurol.2010.4
10.1371/journal.pone.0081673
ContentType Journal Article
Copyright The Authors
2017 The Authors
2017 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer's Association.
2017 The Authors 2017
Copyright_xml – notice: The Authors
– notice: 2017 The Authors
– notice: 2017 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer's Association.
– notice: 2017 The Authors 2017
DBID 6I.
AAFTH
24P
AAYXX
CITATION
NPM
7X8
5PM
DOI 10.1016/j.dadm.2017.01.003
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
Wiley Online Library Open Access
CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList


PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 2352-8729
EndPage 151
ExternalDocumentID PMC5318541
28239639
10_1016_j_dadm_2017_01_003
DAD2JDADM201701003
S2352872917300039
1_s2_0_S2352872917300039
Genre article
Journal Article
GrantInformation_xml – fundername: ZonMW‐Memorabel
GroupedDBID 0R~
0SF
1OC
24P
457
53G
6I.
7RV
7X7
8FI
8FJ
AACTN
AAEDW
AAFTH
AAHHS
AALRI
AAXUO
ABMAC
ABUWG
ACCFJ
ACCMX
ACGFS
ACXQS
ADBBV
ADEZE
ADKYN
ADPDF
ADRAZ
ADVLN
ADZMN
ADZOD
AEEZP
AEQDE
AEVXI
AEXQZ
AFKRA
AFTJW
AGHFR
AITUG
AIWBW
AJBDE
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMRAJ
AOIJS
AVUZU
BAWUL
BENPR
CCPQU
EBS
EJD
EMOBN
FDB
FYUFA
GROUPED_DOAJ
HMCUK
HYE
IAO
IHR
INH
ITC
KQ8
M48
M~E
NAPCQ
NCXOZ
O9-
OK1
OVD
OVEED
PIMPY
ROL
RPM
SSZ
TEORI
UKHRP
WIN
AAYWO
AAYXX
CITATION
PHGZM
PHGZT
NPM
7X8
PPXIY
PUEGO
5PM
ID FETCH-LOGICAL-c4843-d2a5861f426ceb0f6512cfd4974c169135f9f429279ef5b5f3a569631510c1463
IEDL.DBID 24P
ISSN 2352-8729
IngestDate Thu Aug 21 13:54:38 EDT 2025
Fri Sep 05 05:05:14 EDT 2025
Wed Feb 19 02:30:43 EST 2025
Thu Apr 24 23:01:33 EDT 2025
Tue Jul 01 02:13:33 EDT 2025
Wed Jan 22 16:36:22 EST 2025
Fri Feb 23 02:28:49 EST 2024
Tue Feb 25 19:56:33 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Biomarkers
Mild cognitive impairment
Alzheimer's disease
Clinical practice
Dementia
Language English
License This is an open access article under the CC BY-NC-ND license.
Attribution-NonCommercial-NoDerivs
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4843-d2a5861f426ceb0f6512cfd4974c169135f9f429279ef5b5f3a569631510c1463
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1016%2Fj.dadm.2017.01.003
PMID 28239639
PQID 1872583170
PQPubID 23479
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5318541
proquest_miscellaneous_1872583170
pubmed_primary_28239639
crossref_citationtrail_10_1016_j_dadm_2017_01_003
crossref_primary_10_1016_j_dadm_2017_01_003
wiley_primary_10_1016_j_dadm_2017_01_003_DAD2JDADM201701003
elsevier_sciencedirect_doi_10_1016_j_dadm_2017_01_003
elsevier_clinicalkeyesjournals_1_s2_0_S2352872917300039
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – year: 2017
  text: 2017
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Alzheimer's & dementia : diagnosis, assessment & disease monitoring
PublicationTitleAlternate Alzheimers Dement (Amst)
PublicationYear 2017
Publisher Elsevier Inc
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Elsevier
References Herholz, Ebmeier (bib1) 2011; 10
(bib36) 2014; 13
Mattsson, Andreasson, Persson, Carrillo, Collins, Chalbot (bib12) 2013; 9
Klunk, Engler, Nordberg, Wang, Blomqvist, Holt (bib14) 2004; 55
Vanderstichele, Van Kerschaver, Hesse, Davidsson, Buyse, Andreasen (bib26) 2000; 7
Petersen, Smith, Waring, Ivnik, Tangalos, Kokmen (bib31) 1999; 56
Ossenkoppele, Prins, Pijnenburg, Lemstra, van der Flier, Adriaanse (bib37) 2013; 9
McKhann, Knopman, Chertkow, Hyman, Jack, Kawas (bib8) 2011; 7
Koedam, Lehmann, van der Flier, Scheltens, Pijnenburg, Fox (bib22) 2011; 21
Teipel, Drzezga, Grothe, Barthel, Chételat, Schuff (bib35) 2015; 14
Schoonenboom, Reesink, Verwey, Kester, Teunissen, van de Ven (bib9) 2012; 78
Harkins (bib41) 2015; 7
Lutomski, Baars, Schalk, Boter, Buurman, Elzen den (bib20) 2013; 8
Smith, Zhang, Jenkinson, Chen, Matthews, Federico (bib25) 2002; 17
Handels, Wolfs, Aalten, Joore, Verhey, Severens (bib45) 2014; 10
Frisoni, Fox, Jack, Scheltens, Thompson (bib2) 2010; 6
(bib30) 2016
Bloudek, Spackman, Blankenburg, Sullivan (bib34) 2011; 26
Green, Christensen, Cupples, Relkin, Whitehouse, Royal (bib40) 2015; 11
Vanmechelen, Vanderstichele, Davidsson, Van Kerschaver, Van Der Perre, Sjogren (bib27) 2000; 285
Scheltens, Leys, Barkhof, Huglo, Weinstein, Vermersch (bib21) 1992; 55
Prestia, Caroli, Wade, van der Flier, Ossenkoppele, Van Berckel (bib16) 2015; 11
Bouwman, Verwey, Klein, Kok, Blankenstein, Sluimer (bib32) 2010; 30
Dubois, Hampel, Feldman, Scheltens, Aisen, Andrieu (bib4) 2016; 12
Blennow, Zetterberg (bib13) 2015; 9
Vos, Verhey, Frölich, Kornhuber, Wiltfang, Maier (bib18) 2015; 138
Bittner, Zetterberg, Teunissen, Ostlund, Militello, Andreasson (bib28) 2016; 12
Mulder, Verwey, van der Flier, Bouwman, Kok, van Elk (bib10) 2010; 56
Stockman (bib39) 2011; 2011
Mattsson, Zetterberg, Hansson, Andreasen, Parnetti, Jonsson (bib11) 2009; 302
Johnson, Minoshima, Bohnen, Donohoe, Foster, Herscovitch (bib15) 2013; 9
Petersen, Roberts, Knopman, Boeve, Geda, Ivnik (bib19) 2009; 66
Pasquier, Leys, Weerts, Mounier-Vehier, Barkhof, Scheltens (bib23) 1996; 36
Boccardi, Altomare, Ferrari, Festari, Guerra, Paghera (bib38) 2016; 73
Sperling, Johnson (bib7) 2013; 19
van der Flier, Pijnenburg, Prins, Lemstra, Bouwman, Teunissen (bib29) 2014; 41
Sperling, Rentz, Johnson, Karlawish, Donohue, Salmon (bib42) 2014; 6
Ritchie, Molinuevo, Truyen, Satlin, Van der Geyten, Lovestone (bib43) 2016; 3
Fazekas, Chawluk, Alavi, Hurtig, Zimmerman (bib24) 1987; 149
Landau, Harvey, Madison, Reiman, Foster, Aisen (bib17) 2010; 75
Wimo, Religa, Spångberg, Edlund, Winblad, Eriksdotter (bib46) 2013; 28
Blennow, Hampel, Weiner, Zetterberg (bib3) 2010; 6
Richard, Schmand, Eikelenboom, Van Gool (bib33) 2013; 3
Albert, DeKosky, Dickson, Dubois, Feldman, Fox (bib6) 2011; 7
Wimo, Guerchet, Ali, Wu, Prina, Winblad (bib44) 2017; 13
Scheltens, Blennow, Breteler, de Strooper, Frisoni, Salloway (bib5) 2016; 388
2010; 56
2009; 66
2002; 17
2010; 75
2015; 14
2013; 3
2013; 28
1987; 149
2015; 11
2000; 7
2016; 388
2011; 10
2016; 73
1996; 36
2014; 41
2015; 9
2013; 8
2012; 78
1992; 55
2015; 7
2011; 7
2016; 12
2013; 9
2013; 19
2004; 55
2011; 2011
2016; 3
2015; 138
2017; 13
1999; 56
2011; 21
2014; 13
2000; 285
2016
2011; 26
2014; 6
2010; 30
2010; 6
2009; 302
2014; 10
e_1_2_7_6_1
e_1_2_7_5_1
e_1_2_7_4_1
e_1_2_7_3_1
e_1_2_7_9_1
e_1_2_7_7_1
e_1_2_7_19_1
e_1_2_7_18_1
e_1_2_7_17_1
e_1_2_7_16_1
e_1_2_7_2_1
e_1_2_7_15_1
e_1_2_7_41_1
e_1_2_7_14_1
e_1_2_7_13_1
e_1_2_7_43_1
e_1_2_7_12_1
e_1_2_7_44_1
e_1_2_7_11_1
e_1_2_7_45_1
e_1_2_7_10_1
e_1_2_7_46_1
e_1_2_7_47_1
e_1_2_7_26_1
e_1_2_7_27_1
e_1_2_7_28_1
e_1_2_7_29_1
Sperling R. (e_1_2_7_8_1) 2013; 19
Stockman J.A. (e_1_2_7_40_1) 2011; 2011
The Lancet Neurology (e_1_2_7_37_1) 2014; 13
e_1_2_7_30_1
e_1_2_7_25_1
e_1_2_7_24_1
e_1_2_7_32_1
e_1_2_7_23_1
e_1_2_7_33_1
e_1_2_7_22_1
e_1_2_7_34_1
e_1_2_7_21_1
e_1_2_7_35_1
e_1_2_7_20_1
e_1_2_7_36_1
e_1_2_7_38_1
e_1_2_7_39_1
(e_1_2_7_31_1) 2016
Harkins K. (e_1_2_7_42_1) 2015; 7
References_xml – volume: 41
  start-page: 313
  year: 2014
  end-page: 327
  ident: bib29
  article-title: Optimizing patient care and research: the Amsterdam Dementia Cohort
  publication-title: J Alzheimers Dis
– volume: 36
  start-page: 268
  year: 1996
  end-page: 272
  ident: bib23
  article-title: Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts
  publication-title: Eur Neurol
– volume: 17
  start-page: 479
  year: 2002
  end-page: 489
  ident: bib25
  article-title: Accurate, robust, and automated longitudinal and cross-sectional brain change analysis
  publication-title: Neuroimage
– volume: 10
  start-page: 225
  year: 2014
  end-page: 237
  ident: bib45
  article-title: Diagnosing Alzheimer's disease: a systematic review of economic evaluations
  publication-title: Alzheimers Dement
– volume: 78
  start-page: 47
  year: 2012
  end-page: 54
  ident: bib9
  article-title: Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort
  publication-title: Neurology
– year: 2016
  ident: bib30
  publication-title: MAXQDA, software for data analysis, 1989-2016, VERBI software - Consult
– volume: 73
  start-page: 1417
  year: 2016
  end-page: 1424
  ident: bib38
  article-title: Assessment of the incremental diagnostic value of florbetapir F 18 imaging in patients with cognitive impairment
  publication-title: JAMA Neurol
– volume: 8
  start-page: e81673
  year: 2013
  ident: bib20
  article-title: The development of the Older Persons and Informal Caregivers Survey Minimum DataSet (TOPICS-MDS): a large-scale data sharing initiative
  publication-title: PLoS One
– volume: 55
  start-page: 306
  year: 2004
  end-page: 319
  ident: bib14
  article-title: Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
  publication-title: Ann Neurol
– volume: 10
  start-page: 667
  year: 2011
  end-page: 670
  ident: bib1
  article-title: Clinical amyloid imaging in Alzheimer's disease
  publication-title: Lancet Neurol
– volume: 14
  start-page: 1037
  year: 2015
  end-page: 1053
  ident: bib35
  article-title: Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection
  publication-title: Lancet Neurol
– volume: 6
  start-page: 67
  year: 2010
  end-page: 77
  ident: bib2
  article-title: The clinical use of structural MRI in Alzheimer disease
  publication-title: Nat Rev Neurol
– volume: 75
  start-page: 230
  year: 2010
  end-page: 238
  ident: bib17
  article-title: Comparing predictors of conversion and decline in mild cognitive impairment
  publication-title: Neurology
– volume: 26
  start-page: 627
  year: 2011
  end-page: 645
  ident: bib34
  article-title: Review and meta-analysis of biomarkers and diagnostic imaging in Alzheimer's disease
  publication-title: J Alzheimers Dis
– volume: 3
  start-page: 179
  year: 2016
  end-page: 186
  ident: bib43
  article-title: Development of interventions for the secondary prevention of Alzheimer's dementia: the European Prevention of Alzheimer's Dementia (EPAD) project
  publication-title: Lancet Psychiatry
– volume: 19
  start-page: 325
  year: 2013
  end-page: 338
  ident: bib7
  article-title: Biomarkers of Alzheimer disease: current and future applications to diagnostic criteria
  publication-title: Continuum (Minneap Minn)
– volume: 55
  start-page: 967
  year: 1992
  end-page: 972
  ident: bib21
  article-title: Atrophy of medial temporal lobes on MRI in “probable” Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 28
  start-page: 1039
  year: 2013
  end-page: 1044
  ident: bib46
  article-title: Costs of diagnosing dementia: results from SveDem, the Swedish Dementia Registry
  publication-title: Int J Geriatr Psychiatry
– volume: 21
  start-page: 2618
  year: 2011
  end-page: 2625
  ident: bib22
  article-title: Visual assessment of posterior atrophy development of a MRI rating scale
  publication-title: Eur Radiol
– volume: 9
  year: 2013
  ident: bib15
  article-title: Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association
  publication-title: Alzheimers Dement
– volume: 56
  start-page: 303
  year: 1999
  end-page: 308
  ident: bib31
  article-title: Mild cognitive impairment: clinical characterization and outcome
  publication-title: Arch Neurol
– volume: 138
  start-page: 1327
  year: 2015
  end-page: 1338
  ident: bib18
  article-title: Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage
  publication-title: Brain
– volume: 7
  start-page: 245
  year: 2000
  end-page: 258
  ident: bib26
  article-title: Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma
  publication-title: Amyloid
– volume: 56
  start-page: 248
  year: 2010
  end-page: 253
  ident: bib10
  article-title: Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease
  publication-title: Clin Chem
– volume: 9
  start-page: 345
  year: 2015
  ident: bib13
  article-title: The past and the future of Alzheimer's disease CSF biomarkers-a journey toward validated biochemical tests covering the whole spectrum of molecular events
  publication-title: Front Neurosci
– volume: 6
  start-page: 228fs13
  year: 2014
  ident: bib42
  article-title: The A4 study: stopping AD before symptoms begin?
  publication-title: Sci Transl Med
– volume: 7
  start-page: 1
  year: 2015
  end-page: 9
  ident: bib41
  article-title: Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants
  publication-title: Alzheimers Res Ther
– volume: 6
  start-page: 131
  year: 2010
  end-page: 144
  ident: bib3
  article-title: Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
  publication-title: Nat Rev Neurol
– volume: 3
  year: 2013
  ident: bib33
  article-title: MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy study
  publication-title: BMJ Open
– volume: 11
  start-page: 1191
  year: 2015
  end-page: 1201
  ident: bib16
  article-title: Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics
  publication-title: Alzheimers Dement
– volume: 285
  start-page: 49
  year: 2000
  end-page: 52
  ident: bib27
  article-title: Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization
  publication-title: Neurosci Lett
– volume: 12
  start-page: 517
  year: 2016
  end-page: 526
  ident: bib28
  article-title: Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1-42) in human cerebrospinal fluid
  publication-title: Alzheimers Dement
– volume: 12
  start-page: 292
  year: 2016
  end-page: 323
  ident: bib4
  article-title: Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria
  publication-title: Alzheimers Dement
– volume: 388
  start-page: 505
  year: 2016
  end-page: 517
  ident: bib5
  article-title: Alzheimer's disease
  publication-title: Lancet
– volume: 149
  start-page: 351
  year: 1987
  end-page: 356
  ident: bib24
  article-title: MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging
  publication-title: AJR Am J Roentgenol
– volume: 7
  start-page: 263
  year: 2011
  end-page: 269
  ident: bib8
  article-title: The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
  publication-title: Alzheimers Dement
– volume: 13
  start-page: 961
  year: 2014
  ident: bib36
  article-title: Bringing forward the diagnosis of Alzheimer's disease
  publication-title: Lancet Neurol
– volume: 30
  start-page: 1
  year: 2010
  end-page: 7
  ident: bib32
  article-title: New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic population
  publication-title: Dement Geriatr Cogn Disord
– volume: 2011
  start-page: 406
  year: 2011
  end-page: 407
  ident: bib39
  article-title: Disclosure of APOE genotype for risk of Alzheimer's disease
  publication-title: Yearb Pediatr
– volume: 11
  start-page: 1222
  year: 2015
  end-page: 1230
  ident: bib40
  article-title: A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease
  publication-title: Alzheimers Dement
– volume: 13
  start-page: 1
  year: 2017
  end-page: 7
  ident: bib44
  article-title: The worldwide costs of dementia 2015 and comparisons with 2010
  publication-title: Alzheimers Dement
– volume: 9
  start-page: 414
  year: 2013
  end-page: 421
  ident: bib37
  article-title: Impact of molecular imaging on the diagnostic process in a memory clinic
  publication-title: Alzheimers Dement
– volume: 7
  start-page: 270
  year: 2011
  end-page: 279
  ident: bib6
  article-title: The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
  publication-title: Alzheimers Dement
– volume: 302
  start-page: 385
  year: 2009
  end-page: 393
  ident: bib11
  article-title: CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment
  publication-title: JAMA
– volume: 9
  start-page: 251
  year: 2013
  end-page: 261
  ident: bib12
  article-title: CSF biomarker variability in the Alzheimer's Association quality control program
  publication-title: Alzheimers Dement
– volume: 66
  start-page: 1447
  year: 2009
  end-page: 1455
  ident: bib19
  article-title: Mild cognitive impairment: ten years later
  publication-title: Arch Neurol
– volume: 30
  start-page: 1
  year: 2010
  end-page: 7
  article-title: New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic population
  publication-title: Dement Geriatr Cogn Disord
– volume: 66
  start-page: 1447
  year: 2009
  end-page: 1455
  article-title: Mild cognitive impairment: ten years later
  publication-title: Arch Neurol
– volume: 55
  start-page: 306
  year: 2004
  end-page: 319
  article-title: Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
  publication-title: Ann Neurol
– volume: 12
  start-page: 517
  year: 2016
  end-page: 526
  article-title: Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β‐amyloid (1‐42) in human cerebrospinal fluid
  publication-title: Alzheimers Dement
– volume: 12
  start-page: 292
  year: 2016
  end-page: 323
  article-title: Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria
  publication-title: Alzheimers Dement
– volume: 55
  start-page: 967
  year: 1992
  end-page: 972
  article-title: Atrophy of medial temporal lobes on MRI in “probable” Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 56
  start-page: 303
  year: 1999
  end-page: 308
  article-title: Mild cognitive impairment: clinical characterization and outcome
  publication-title: Arch Neurol
– volume: 6
  year: 2014
  article-title: The A4 study: stopping AD before symptoms begin?
  publication-title: Sci Transl Med
– volume: 3
  year: 2013
  article-title: MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy study
  publication-title: BMJ Open
– volume: 9
  start-page: 345
  year: 2015
  article-title: The past and the future of Alzheimer's disease CSF biomarkers‐a journey toward validated biochemical tests covering the whole spectrum of molecular events
  publication-title: Front Neurosci
– volume: 3
  start-page: 179
  year: 2016
  end-page: 186
  article-title: Development of interventions for the secondary prevention of Alzheimer's dementia: the European Prevention of Alzheimer's Dementia (EPAD) project
  publication-title: Lancet Psychiatry
– volume: 7
  start-page: 245
  year: 2000
  end-page: 258
  article-title: Standardization of measurement of beta‐amyloid(1‐42) in cerebrospinal fluid and plasma
  publication-title: Amyloid
– volume: 78
  start-page: 47
  year: 2012
  end-page: 54
  article-title: Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort
  publication-title: Neurology
– volume: 14
  start-page: 1037
  year: 2015
  end-page: 1053
  article-title: Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection
  publication-title: Lancet Neurol
– volume: 11
  start-page: 1222
  year: 2015
  end-page: 1230
  article-title: A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease
  publication-title: Alzheimers Dement
– volume: 10
  start-page: 667
  year: 2011
  end-page: 670
  article-title: Clinical amyloid imaging in Alzheimer's disease
  publication-title: Lancet Neurol
– volume: 36
  start-page: 268
  year: 1996
  end-page: 272
  article-title: Inter‐ and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts
  publication-title: Eur Neurol
– volume: 388
  start-page: 505
  year: 2016
  end-page: 517
  article-title: Alzheimer's disease
  publication-title: Lancet
– volume: 26
  start-page: 627
  year: 2011
  end-page: 645
  article-title: Review and meta‐analysis of biomarkers and diagnostic imaging in Alzheimer's disease
  publication-title: J Alzheimers Dis
– year: 2016
– volume: 7
  start-page: 270
  year: 2011
  end-page: 279
  article-title: The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
  publication-title: Alzheimers Dement
– volume: 8
  year: 2013
  article-title: The development of the Older Persons and Informal Caregivers Survey Minimum DataSet (TOPICS‐MDS): a large‐scale data sharing initiative
  publication-title: PLoS One
– volume: 56
  start-page: 248
  year: 2010
  end-page: 253
  article-title: Amyloid‐beta(1‐42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease
  publication-title: Clin Chem
– volume: 19
  start-page: 325
  year: 2013
  end-page: 338
  article-title: Biomarkers of Alzheimer disease: current and future applications to diagnostic criteria
  publication-title: Continuum (Minneap Minn)
– volume: 11
  start-page: 1191
  year: 2015
  end-page: 1201
  article-title: Prediction of AD dementia by biomarkers following the NIA‐AA and IWG diagnostic criteria in MCI patients from three European memory clinics
  publication-title: Alzheimers Dement
– volume: 302
  start-page: 385
  year: 2009
  end-page: 393
  article-title: CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment
  publication-title: JAMA
– volume: 28
  start-page: 1039
  year: 2013
  end-page: 1044
  article-title: Costs of diagnosing dementia: results from SveDem, the Swedish Dementia Registry
  publication-title: Int J Geriatr Psychiatry
– volume: 7
  start-page: 1
  year: 2015
  end-page: 9
  article-title: Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants
  publication-title: Alzheimers Res Ther
– volume: 41
  start-page: 313
  year: 2014
  end-page: 327
  article-title: Optimizing patient care and research: the Amsterdam Dementia Cohort
  publication-title: J Alzheimers Dis
– volume: 13
  start-page: 961
  year: 2014
  article-title: Bringing forward the diagnosis of Alzheimer's disease
  publication-title: Lancet Neurol
– volume: 21
  start-page: 2618
  year: 2011
  end-page: 2625
  article-title: Visual assessment of posterior atrophy development of a MRI rating scale
  publication-title: Eur Radiol
– volume: 9
  start-page: 414
  year: 2013
  end-page: 421
  article-title: Impact of molecular imaging on the diagnostic process in a memory clinic
  publication-title: Alzheimers Dement
– volume: 13
  start-page: 1
  year: 2017
  end-page: 7
  article-title: The worldwide costs of dementia 2015 and comparisons with 2010
  publication-title: Alzheimers Dement
– volume: 7
  start-page: 263
  year: 2011
  end-page: 269
  article-title: The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
  publication-title: Alzheimers Dement
– volume: 9
  year: 2013
  article-title: Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association
  publication-title: Alzheimers Dement
– volume: 17
  start-page: 479
  year: 2002
  end-page: 489
  article-title: Accurate, robust, and automated longitudinal and cross‐sectional brain change analysis
  publication-title: Neuroimage
– volume: 6
  start-page: 131
  year: 2010
  end-page: 144
  article-title: Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
  publication-title: Nat Rev Neurol
– volume: 73
  start-page: 1417
  year: 2016
  end-page: 1424
  article-title: Assessment of the incremental diagnostic value of florbetapir F 18 imaging in patients with cognitive impairment
  publication-title: JAMA Neurol
– volume: 138
  start-page: 1327
  year: 2015
  end-page: 1338
  article-title: Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage
  publication-title: Brain
– volume: 6
  start-page: 67
  year: 2010
  end-page: 77
  article-title: The clinical use of structural MRI in Alzheimer disease
  publication-title: Nat Rev Neurol
– volume: 9
  start-page: 251
  year: 2013
  end-page: 261
  article-title: CSF biomarker variability in the Alzheimer's Association quality control program
  publication-title: Alzheimers Dement
– volume: 75
  start-page: 230
  year: 2010
  end-page: 238
  article-title: Comparing predictors of conversion and decline in mild cognitive impairment
  publication-title: Neurology
– volume: 285
  start-page: 49
  year: 2000
  end-page: 52
  article-title: Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization
  publication-title: Neurosci Lett
– volume: 149
  start-page: 351
  year: 1987
  end-page: 356
  article-title: MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging
  publication-title: AJR Am J Roentgenol
– volume: 2011
  start-page: 406
  year: 2011
  end-page: 407
  article-title: Disclosure of APOE genotype for risk of Alzheimer's disease
  publication-title: Yearb Pediatr
– volume: 10
  start-page: 225
  year: 2014
  end-page: 237
  article-title: Diagnosing Alzheimer's disease: a systematic review of economic evaluations
  publication-title: Alzheimers Dement
– ident: e_1_2_7_5_1
  doi: 10.1016/j.jalz.2016.02.002
– ident: e_1_2_7_43_1
  doi: 10.1126/scitranslmed.3007941
– ident: e_1_2_7_26_1
  doi: 10.1006/nimg.2002.1040
– ident: e_1_2_7_12_1
  doi: 10.1001/jama.2009.1064
– ident: e_1_2_7_45_1
  doi: 10.1016/j.jalz.2016.07.150
– ident: e_1_2_7_13_1
  doi: 10.1016/j.jalz.2013.01.010
– ident: e_1_2_7_34_1
  doi: 10.1136/bmjopen‐2012‐002541
– volume: 7
  start-page: 1
  year: 2015
  ident: e_1_2_7_42_1
  article-title: Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants
  publication-title: Alzheimers Res Ther
  doi: 10.1186/s13195-015-0112-7
– ident: e_1_2_7_2_1
  doi: 10.1016/S1474-4422(11)70123-5
– ident: e_1_2_7_20_1
  doi: 10.1001/archneurol.2009.266
– ident: e_1_2_7_36_1
  doi: 10.1016/S1474-4422(15)00093-9
– ident: e_1_2_7_3_1
  doi: 10.1038/nrneurol.2009.215
– ident: e_1_2_7_17_1
  doi: 10.1016/j.jalz.2014.12.001
– ident: e_1_2_7_24_1
  doi: 10.1159/000117270
– ident: e_1_2_7_16_1
  doi: 10.1016/j.jalz.2013.01.002
– ident: e_1_2_7_18_1
  doi: 10.1212/WNL.0b013e3181e8e8b8
– volume: 2011
  start-page: 406
  year: 2011
  ident: e_1_2_7_40_1
  article-title: Disclosure of APOE genotype for risk of Alzheimer's disease
  publication-title: Yearb Pediatr
  doi: 10.1016/S0084-3954(09)79610-1
– ident: e_1_2_7_33_1
  doi: 10.1159/000315542
– ident: e_1_2_7_7_1
  doi: 10.1016/j.jalz.2011.03.008
– ident: e_1_2_7_38_1
  doi: 10.1016/j.jalz.2012.07.003
– ident: e_1_2_7_15_1
  doi: 10.1002/ana.20009
– ident: e_1_2_7_19_1
  doi: 10.1093/brain/awv029
– ident: e_1_2_7_39_1
  doi: 10.1001/jamaneurol.2016.3751
– ident: e_1_2_7_41_1
  doi: 10.1016/j.jalz.2014.10.014
– ident: e_1_2_7_22_1
  doi: 10.1136/jnnp.55.10.967
– ident: e_1_2_7_25_1
  doi: 10.2214/ajr.149.2.351
– ident: e_1_2_7_44_1
  doi: 10.1016/S2215-0366(15)00454-X
– ident: e_1_2_7_32_1
  doi: 10.1001/archneur.56.3.303
– ident: e_1_2_7_10_1
  doi: 10.1212/WNL.0b013e31823ed0f0
– volume-title: MAXQDA, software for data analysis, 1989‐2016, VERBI software ‐ Consult
  year: 2016
  ident: e_1_2_7_31_1
– ident: e_1_2_7_30_1
  doi: 10.3233/JAD-132306
– ident: e_1_2_7_29_1
  doi: 10.1016/j.jalz.2015.09.009
– ident: e_1_2_7_11_1
  doi: 10.1373/clinchem.2009.130518
– ident: e_1_2_7_28_1
  doi: 10.1016/S0304-3940(00)01036-3
– ident: e_1_2_7_6_1
  doi: 10.1016/S0140-6736(15)01124-1
– ident: e_1_2_7_14_1
  doi: 10.3389/fnins.2015.00345
– ident: e_1_2_7_27_1
  doi: 10.3109/13506120009146438
– volume: 13
  start-page: 961
  year: 2014
  ident: e_1_2_7_37_1
  article-title: Bringing forward the diagnosis of Alzheimer's disease
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(14)70211-X
– ident: e_1_2_7_46_1
  doi: 10.1016/j.jalz.2013.02.005
– ident: e_1_2_7_47_1
  doi: 10.1002/gps.3925
– ident: e_1_2_7_23_1
  doi: 10.1007/s00330-011-2205-4
– ident: e_1_2_7_35_1
  doi: 10.3233/JAD-2011-110458
– volume: 19
  start-page: 325
  year: 2013
  ident: e_1_2_7_8_1
  article-title: Biomarkers of Alzheimer disease: current and future applications to diagnostic criteria
  publication-title: Continuum (Minneap Minn)
– ident: e_1_2_7_9_1
  doi: 10.1016/j.jalz.2011.03.005
– ident: e_1_2_7_4_1
  doi: 10.1038/nrneurol.2010.4
– ident: e_1_2_7_21_1
  doi: 10.1371/journal.pone.0081673
SSID ssj0001492410
Score 2.286148
Snippet Abstract Introduction The Alzheimer's biomarkers in daily practice (ABIDE) project is designed to translate knowledge on diagnostic tests (magnetic resonance...
The Alzheimer's biomarkers in daily practice (ABIDE) project is designed to translate knowledge on diagnostic tests (magnetic resonance imaging [MRI],...
Introduction The Alzheimer's biomarkers in daily practice (ABIDE) project is designed to translate knowledge on diagnostic tests (magnetic resonance imaging...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 143
SubjectTerms Alzheimer's disease
Biomarkers
Clinical practice
Dementia
Diagnostic Assessment & Prognosis
Mild cognitive impairment
Neurology
Other
SummonAdditionalLinks – databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dSxwxEA-iL75IRa1XrUQQ2lJWkk2yHxaRww9EOB9aD3wLuU2CJ9e99vYE9a_vzG72VPyg4Mtyu7fZsDOTzG-ymd8QsgNRRmLjJIsyzkwkAVBEufCgEG95ZlhsZE272DtPTvvy7FJdzpG23FEQYPViaIf1pPqT0e7t37sDGPD7D3u1rLGYVc7TmoITyT8XwDPFaOW9APevm2gALrO63pzCiSDOQx7Ny495zVc9x6LPt1Q-hrq1rzr5QJYCyKTdxiqWyZwrV8h5d3R_5Ya_3eRLRTHrHjfmTCo6LKk1w9EdbROm6NcuzN_H32hYpdmjP8OKoaOmtNTWmz5WSf_k-OLwNArVFKJCZlJENjYqS7gHl1y4AfMJuPrCWwkBRYGMOUL53GPxqjR3Xg2UF0YlMDwBErAC5lOxRubLcenWCeVWGitTz4VLZOrkoLBwyowVSgqXsQ7hrdx0EajGseLFSLd7yq41ylqjrDXjSFDaId9nbf40RBtv3p226tBtCilMeq5qDUhzXcWa6V-oaVQ0R2J-JvIOUbOWAWQ04EGDSb3Z43ardQ0jED-rmNKNb6AneLzKAIfBe39srGD2BhDQCpAh9Jo-sY_ZDcju_fSfcnhVs3wrzGuXvEN-1Jb0H0LRR92j-AwOPbwIgTYTn97VeoMs4u9mxWmTzE8nN-4zYLDpYKseWP8Ai1slig
  priority: 102
  providerName: Scholars Portal
Title Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and design
URI https://www.clinicalkey.es/playcontent/1-s2.0-S2352872917300039
https://dx.doi.org/10.1016/j.dadm.2017.01.003
https://onlinelibrary.wiley.com/doi/abs/10.1016%2Fj.dadm.2017.01.003
https://www.ncbi.nlm.nih.gov/pubmed/28239639
https://www.proquest.com/docview/1872583170
https://pubmed.ncbi.nlm.nih.gov/PMC5318541
Volume 6
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2352-8729
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001492410
  issn: 2352-8729
  databaseCode: KQ8
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2352-8729
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001492410
  issn: 2352-8729
  databaseCode: KQ8
  dateStart: 20150301
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2352-8729
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001492410
  issn: 2352-8729
  databaseCode: DOA
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2352-8729
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001492410
  issn: 2352-8729
  databaseCode: M~E
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 2352-8729
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001492410
  issn: 2352-8729
  databaseCode: RPM
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVOVD
  databaseName: Journals@Ovid LWW All Open Access Journal Collection Rolling
  customDbUrl:
  eissn: 2352-8729
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001492410
  issn: 2352-8729
  databaseCode: OVEED
  dateStart: 20150301
  isFulltext: true
  titleUrlDefault: http://ovidsp.ovid.com/
  providerName: Ovid
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 2352-8729
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001492410
  issn: 2352-8729
  databaseCode: 7X7
  dateStart: 20150901
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 2352-8729
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001492410
  issn: 2352-8729
  databaseCode: BENPR
  dateStart: 20150901
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 2352-8729
  dateEnd: 20250731
  omitProxy: true
  ssIdentifier: ssj0001492410
  issn: 2352-8729
  databaseCode: M48
  dateStart: 20150301
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
– providerCode: PRVWIB
  databaseName: KBPluse Wiley Online Library: Open Access
  customDbUrl:
  eissn: 2352-8729
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001492410
  issn: 2352-8729
  databaseCode: AVUZU
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: https://www.kbplus.ac.uk/kbplus7/publicExport/pkg/559
  providerName: Wiley-Blackwell
– providerCode: PRVWIB
  databaseName: Wiley Online Library Open Access
  customDbUrl:
  eissn: 2352-8729
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001492410
  issn: 2352-8729
  databaseCode: 24P
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bSxwxFA6iL76UFrXdXpYIBZUykEySubRPq7siwi5iK-xbyEwSXFnHsqMP7a_vOZmLWqkUfAm7s5MJcy45lz3nCyGfIcpIbJxkUcaZiSQ4FFEuPDDEW54ZFhsZYBens-TkQp7O1XyNjLtemAYfok-4oWaE_RoV3BT1g3jzCkJii73kPA3Amwj5ucHR_CO-szy7z7RIiDECLEEM3gaof5y33TNNodffj_mXhXrqgT4tpHzo4AYLdfyavGpdSzpqZOENWXPVFpmNlr8v3eLarfZqir32WI6zqumiotYslr9o1yZF90ewa08OaJub-UrP2zyho6ay1IZSj21ycTz5cXQStWcoRKXMpIhsbFSWcA-GuHQF8wkY-NJbCWFEiTg5Qvnc45FVae68KpQXRiWglOAIsBJ2UbFD1qubyr0jlFtprEw9Fy6RqZNFaeErM1YoKVzGBoR3dNNlCzCO51wsdVdJdqWR1hpprRlHWNIB-dLP-dnAazx7d9qxQ3eNo7DVubrVu1pzXcea6e_IaWQ0Rzh-JvIBUf3M1rVoXAYNgvXsirsd1zXoHf6ZYip3cwcrweNVBt4XvPfbRgr6N4AwVgANYdX0kXz0NyCm9-NfqsVlwPZW2M0u-YB8C5L0H0TR49E4PoVhihchvGbi_YtmfyCb-LnJM30k67erO_cJPK_bYhgUC8Z0ng7JxuFkdnY-DFkMGKcy-wNkliUi
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1baxNBFB5KfdAXUayaWusUBCuyMNe92KdgU2JtQtEW-jZMdmZoStxKtn2ov95zZi_2QovgSyCbnR32XGa-c3LON4S8hygjdSLNk5wzmygAFEkhAygkOJ5bJqyKtIuTaTo-Vvsn-mSFjLpemIYfok-4oWfE9RodHBPS1wLOM4iJHTaT8ywybyLn5yOVCobGLdTh31SLgiAj8hIIgBvg_6Jo22eaSq_bj7lvi7oLQe9WUl5HuHGL2ntGnrbYkg4bY3hOVnz1gkyHi9-nfv7TLz_UFJvtsR5nWdN5RZ2dL65o1ydFt4ewbI8-0jY585l-bxOFntrKURdrPdbI8d7o6Ms4aQ9RSEqVK5k4YXWe8gA7celnLKSww5fBKYgjSiTKkToUAc-sygof9EwHaXUKXglIgJWwjMqXZLU6r_xrQrlT1qkscOlTlXk1Kx18ZdZJraTP2YDwTm6mbBnG8aCLhelKyc4MytqgrA3jyEs6IJ_6Mb8afo0H7846dZiucxTWOl-3jlcbbmphmPmBmkZFc-TjZ7IYEN2PbLFFgxkMWNaDM251WjfgePhviq38-SXMBI_XOcAveO9XjRX0bwBxrAQZwqzZDfvob0BS75u_VPPTSO6tsZ1d8QHZiZb0D0Ixu8NdsQ8fE7wI8TWT6_81-h15PD6aHJiDr9Nvb8gTvN4knTbI6sXy0r8FGHYx24xO9gd4-CRB
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1ZaxsxEBYmhZKX0pIeTo-oUGhKWZBW0h7tk6lt0rQxIWkgb0JeScTBXRuv_dD--s5oj1w0FPpi8Hq1YueQvhnPfCLkHUQZiY2TLMo4M5EEQBHlwoNCvOWZYbGRgXbxaJIcnMnDc3XeI8O2F6bmh-gSbugZYb1GB19afy3evISQ2GIvOU8D8SZSfj6QyN2C_M7y-CrTIiHGCLQEMaANcP84b7pn6kKv24_52w51F4HeLaS8DnDDDjV-TB410JIOalt4Qnqu3CGTwfz3hZv9dKv3FcVeeyzHWVV0VlJrZvNftG2TovsDWLVHH2iTm_lET5o8oaOmtNSGUo-n5Gw8-vHlIGrOUIgKmUkR2dioLOEeNuLCTZlPYIMvvJUQRhTIkyOUzz0eWZXmzqup8sKoBJwSgAArYBUVz8hWuSjdC0K5lcbK1HPhEpk6OS0sfGXGCiWFy1if8FZuumgIxvGci7luK8kuNcpao6w140hL2icfuzHLml7j3rvTVh26bRyFpc5Vjd9Vmusq1kyfoqZR0Rzp-JnI-0R1IxtoUUMGDYZ174xvW61r8Dv8M8WUbrGBmeDxKgP0Be_9vLaC7g0gjBUgQ5g1vWEf3Q3I6X3zl3J2Ebi9FXazS94nn4Ml_YNQ9HAwjA_h4wgvQnjNxO5_jd4jD4-HY_396-TbS7KNl-uU0yuytV5t3GsAYevpm-BjfwCc5SNz
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Alzheimer%27s+biomarkers+in+daily+practice+%28ABIDE%29+project%3A+Rationale+and+design&rft.jtitle=Alzheimer%27s+%26+dementia+%3A+diagnosis%2C+assessment+%26+disease+monitoring&rft.au=Wilde%2C+Arno&rft.au=Maurik%2C+Ingrid+S.&rft.au=Kunneman%2C+Marleen&rft.au=Bouwman%2C+Femke&rft.date=2017&rft.issn=2352-8729&rft.eissn=2352-8729&rft.volume=6&rft.issue=1&rft.spage=143&rft.epage=151&rft_id=info:doi/10.1016%2Fj.dadm.2017.01.003&rft.externalDBID=10.1016%252Fj.dadm.2017.01.003&rft.externalDocID=DAD2JDADM201701003
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2352-8729&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2352-8729&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2352-8729&client=summon